Screener
Protagonist Therapeutics PTGX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Other (expense) income, net | (81) | 36 | (28) | 118 |
| Income (loss) before income tax expense | 165,114 | (34,599) | 167,395 | (46,254) |
| Income tax expense | 2,265 | 172 | 763 | 172 |
| Net income (loss) | $162,849 | $(34,771) | $166,632 | $(46,426) |
| Net income (loss) per share, basic | $2.47 | $(0.55) | $2.54 | $(0.73) |
| Net income (loss) per share, diluted | $2.29 | $(0.55) | $2.35 | $(0.73) |
| Weighted-average shares used to compute net income (loss) per share, basic | 65,935,769 | 63,510,537 | 65,514,150 | 63,238,682 |
| Weighted-average shares used to compute net income (loss) per share, diluted | 71,007,011 | 63,510,537 | 70,818,718 | 63,238,682 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Protagonist Therapeutics's shares (diluted)?
- Protagonist Therapeutics (PTGX) reported shares (diluted) of 71M in Q2 2026.
- How has Protagonist Therapeutics's shares (diluted) changed year-over-year?
- Protagonist Therapeutics's shares (diluted) increased by 11.8% year-over-year, from 63.5M to 71M.
- What is the long-term trend for Protagonist Therapeutics's shares (diluted)?
- Over 4 years (2021 to 2025), Protagonist Therapeutics's shares (diluted) has grown at a 8.5% compound annual growth rate (CAGR), from 183.4M to 253.8M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Protagonist Therapeutics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude